News

A recent press briefing by the Infectious Diseases Society of America (IDSA) addressed the need to have new antibiotics in the pipeline to answer the rising challenge of drug resistance.

A group of personnel at a veterans administration medical center (VAMC)) did a drive-thru to help bolster vaccination amongst coworkers.

The biosensor detects fragments of the SARS-CoV-2 virus as well as variants.

Understanding how future waves will impact areas can help officials implement policies to mitigate them.

Those taking methotrexate had lower seroconversion rates compared to controls.

Providing "social normative feedback" to physicians succeeded in lowering antibiotic treatment duration and cost, with less effect on prescription volume.

A meeting between developers and federal experts was inconclusive to the necessity of a third mRNA dose for COVID-19.

The CDC announced 100 preliminary cases of Guillain-Barré syndrome following vaccine administration.

While infection risk is not eliminated, the vaccine still provided significant protection.

The second wave in South Africa was larger and saw the Beta lineage dominate.

Investigators followed patients with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) for 6 months to review their outcomes.

This serious adverse event has been linked with COVID-19 shots from AstraZeneca and Janssen.

A Swiss population-based study showed more people in socioeconomically challenged places tested positive more frequently, saw higher hospitalizations, and greater mortality rates than those in higher socioeconomic places.

Azithromycin versus standard care in patients with mild-to-moderate COVID-19, did not reduce the risk of hospital admission or mortality.

Patients who developed atrial fibrillation had higher levels of two known markers of heart stress.

The company’s RBX2660, administered as a single dose, demonstrated superiority over standard of care for reducing Clostridioides difficile infection (CDI) recurrence.

Interventions after students receive a positive test were ineffective at preventing more infections.

The agency is making the safe return to school in the fall their top priority.

The announcement aligns with an FDA and CDC statement against the need for booster doses.

Kansas counties that adopted mask mandates saw a 60% drop in COVID-19 cases, a new study found.

In the second installment of an interview, members of the FlowMetric Life Sciences' leadership discuss how their technology might aid possible COVID-19 vaccine booster shots, how immunocompromised patients respond to vaccines, and other vaccines where their platform may be used.

Dengue epidemics can occur annually and are caused by specific mosquitoes, but introducing bacteria to the mosquitoes can reduce the transmission of the infection.

The Sinovac developed vaccine could greatly aid in the global inoculation effort.

A study looked at COVID-19 incidence rates in health care workers who wore medical masks vs respirator masks when performing nonaerosolizing, routine patient care.

Two doses of the Pfizer or AstraZeneca vaccines generated high sero-neutralization against the strain.

While the efficacy of SARS-CoV-2 vaccines have been demonstrated, a lack of data is present for patients with cancer.

CDC says infections linked to the consumption of Jule’s Cashew Brie, a vegan, or plant-based cheese alternative, was linked to the cashews used in the ingredients.

FlowMetric, Inc., discusses its VaxEffect, an immune monitoring platform and how it can be used to measure COVID-19 vaccine responses.

The company’s mRNA-1010 is a seasonal influenza vaccine candidate that is targeting A H1N1, H3N2, influenza B Yamagata, and Victoria lineages.

Benefits were also observed among adults aged 18 to 49, with adults over 65 seeing the most benefit.